Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
DERM
vs
S&P 500
DERM
S&P 500
Over the past 12 months, DERM has underperformed S&P 500, delivering a return of -37% compared to S&P 500's +11% growth.
Stocks Performance
DERM vs S&P 500
Performance Gap
DERM vs S&P 500
Performance By Year
DERM vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Journey Medical Corp
Glance View
Journey Medical Corp is a specialty pharmaceutical company focused on prescription medicines for skin conditions. It sells treatments used by dermatologists and other prescribers for problems such as acne, fungal infections, rosacea, and other common dermatology needs. Its products are sold through pharmacies to patients after a doctor writes a prescription. The company makes money mainly by selling these branded dermatology products and, in some cases, by commercializing medicines it has licensed or acquired rights to. Its customers are the doctors who prescribe the treatments, the pharmacies that dispense them, and ultimately the patients who use them. Instead of trying to be a broad drugmaker, Journey Medical concentrates on a narrow part of the pharmaceutical market where skin specialists make repeat, practical treatment choices. That focus gives the business a clear role in the drug value chain: it takes already-developed dermatology medicines and turns them into marketed products with sales, distribution, and physician outreach. This makes Journey Medical different from large drug companies that spend heavily on broad research or hospital drugs. Its business depends more on selecting the right skin-care medicines, building relationships with dermatology practices, and keeping those products available through prescription channels.